Goodwin Advises Amylyx Pharmaceuticals on $575 Million Public Offering
August 25, 2026
August 25, 2026
BOSTON, Massachusetts, Aug. 25 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:
* * *
Goodwin Advises Amylyx Pharmaceuticals on $575 Million Public Offering
*
The Life Sciences team advised Amylyx Pharmaceuticals, Inc. ("Amylyx") (Nasdaq: AMLX) on an upsized underwritten public offering of 16,203,500 shares of its common stock at a public offering price of $35.50 per share, which included the full ex . . .
* * *
Goodwin Advises Amylyx Pharmaceuticals on $575 Million Public Offering
*
The Life Sciences team advised Amylyx Pharmaceuticals, Inc. ("Amylyx") (Nasdaq: AMLX) on an upsized underwritten public offering of 16,203,500 shares of its common stock at a public offering price of $35.50 per share, which included the full ex . . .